Vaccination

Experimental COVID-19 vaccine safe, generates immune response

An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), was generally well tolerated and prompted neutralizing antibody activity in healthy ...

Medical research

New antiviral therapy may block COVID-19 transmission

By the time you test positive for COVID-19, the SARS-CoV-2 virus has already taken up residence in your respiratory system. With each breath, you expel invisible viral particles into the air—a process known as viral shedding. ...

Immunology

A new approach to study autoimmune diseases

A team of researchers led by the Indiana Biosciences Research Institute Diabetes Center's Scientific Director Decio L. Eizirik, MD, Ph.D., has found that identifying new treatments for autoimmune diseases requires studying ...

Diseases, Conditions, Syndromes

UK researchers cure man who had COVID for 411 days

British researchers announced Friday they have cured a man who was continually infected with COVID for 411 days by analyzing the genetic code of his particular virus to find the right treatment.

Diseases, Conditions, Syndromes

Good news on blocking a virus considered a global threat

Scientists have reported good news on the pandemic preparedness front: A cocktail of four manufactured antibodies is effective at neutralizing a virus from the Henipavirus family, a group of pathogens considered to be a global ...

Diseases, Conditions, Syndromes

Another tantalizing step closer to a universal flu vaccine

Development of a universal flu vaccine has been a long-sought goal, and as flu scientists begin to see light at the end of a decades-long tunnel, encouraging data have emerged on an experimental shot. It appears effective ...

page 8 from 40